In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020
Journal
International journal of antimicrobial agents
Journal Volume
61
Journal Issue
6
Date Issued
2023-04-13
Author(s)
Abstract
Antimicrobial resistance due to β-lactamase production is a worldwide issue, and β-lactamase inhibitors have been developed to overcome the growing problem. This study aimed to evaluate the in vitro activities of two recently introduced carbapenem/β-lactamase inhibitor combinations - imipenem/relebactam and meropenem/vaborbactam - and their comparators against Enterobacterales from patients with urinary tract infections (UTIs).
Subjects
Carbapenem resistance; Cross-resistance; Enterobacterales; Multidrug resistance; Novel β-lactam combination agents
SDGs
Type
journal article